{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T08:45:54Z","timestamp":1759481154254},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2004,8,25]],"date-time":"2004-08-25T00:00:00Z","timestamp":1093392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,8,31]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n               <jats:p>Myeloperoxidase (MPO) is one of the major target antigens of antineutrophil cytoplasmic antibodies (ANCA) in primary systemic vasculitis. It is known that propylthiouracil (PTU) could induce MPO\u2013ANCA-positive vasculitis. The production of anti-MPO antibodies in patients with PTU-induced vasculitis may be different from that in patients with primary microscopic polyangiitis (MPA). One possible reason for this may be differences in epitope recognition. The aim of this study is to compare the epitopes of antibodies to MPO in sera from patients with PTU-induced vasculitis (n = 10) and MPA (n = 10). The sera were collected and used to inhibit monoclonal antibodies against human MPO (3D8 and 6B9) and affinity purified, horseradish peroxidase conjugated human anti-MPO antibodies (Pab1-HRP, Pab2-HRP) in a competitive inhibition enzyme-linked immunosorbent assay (ELISA) system using soluble human MPO as solid phase ligand. The Pab1-HRP and Pab2-HRP were affinity purified from plasma exchanges of a patient with PTU-induced vasculitis and a patient with MPA, respectively. The inhibition rates were evaluated and compared between the PTU and primary MPA groups. In the PTU group all 10 sera could inhibit 3D8: the average inhibition rate was 44.7% \u00b1 5.0%; 9\/10 sera could inhibit 6B9: the average inhibition rate was 35.6% \u00b1 6.0%. However, in the MPA group all 10 sera could inhibit 3D8 and 6B9; the average inhibition rates were 68.4% \u00b1 16.1% (P\u2003&amp;lt;\u20030.01) and 62.2% \u00b1 17.2% (P\u2003&amp;lt;\u20030.01), respectively. Sera in both the PTU and MPA groups could inhibit Pab1-HRP and the inhibition rates were 81.4% \u00b1 9.4%versus 86.6% \u00b1 17.2% (P\u2003&amp;gt;\u20030.05). However, the average inhibition rate for Pab2-HRP in the MPA group was significantly higher than that in the PTU group (76.3% \u00b1 7.8%versus 58.9% \u00b1 15.5%, P\u2003&amp;lt;\u20030.01). We conclude that anti-MPO antibodies from patients with PTU-induced vasculitis and from patients with primary MPA could recognize more than one epitope on the native MPO molecule. Although the epitopes overlapped between the two groups, the epitopes of anti-MPO antibodies from patients with PTU-induced vasculitis might be more restricted.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2004.02557.x","type":"journal-article","created":{"date-parts":[[2004,9,16]],"date-time":"2004-09-16T13:49:46Z","timestamp":1095342586000},"page":"179-182","source":"Crossref","is-referenced-by-count":21,"title":["Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule"],"prefix":"10.1093","volume":"138","author":[{"given":"H","family":"YE","sequence":"first","affiliation":[{"name":"Departments of Nephrology"},{"name":"Endocrinology, Peking University First Hospital, Beijing, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M-H","family":"ZHAO","sequence":"additional","affiliation":[{"name":"Departments of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"GAO","sequence":"additional","affiliation":[{"name":"Endocrinology, Peking University First Hospital, Beijing, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X-H","family":"GUO","sequence":"additional","affiliation":[{"name":"Endocrinology, Peking University First Hospital, Beijing, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-Y","family":"WANG","sequence":"additional","affiliation":[{"name":"Departments of Nephrology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2004,8,25]]},"reference":[{"key":"2022010901424758900_b1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","article-title":"Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy","volume":"342","author":"Dolman","year":"1993","journal-title":"Lancet"},{"key":"2022010901424758900_b2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2022010901424758900_b3","first-page":"1","article-title":"The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism","volume":"31","author":"Gao","year":"2004","journal-title":"Endocr Res"},{"key":"2022010901424758900_b4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1681\/ASN.V132437","article-title":"Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment","volume":"13","author":"Fujieda","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2022010901424758900_b5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0022-1759(96)00123-8","article-title":"A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal\/permeability-increasing protein from human neutrophil granule acid extract","volume":"197","author":"Zhao","year":"1996","journal-title":"J Immunol Meth"},{"key":"2022010901424758900_b6","volume-title":"Affinity chromatography principles and methods","author":"Pharmacia LKB Biotechnology."},{"key":"2022010901424758900_b7","first-page":"1051","article-title":"Immunocytochemical antigen-specific detection of antibodies","volume-title":"Immunology methods manual","author":"Claassen","year":"1997"},{"key":"2022010901424758900_b8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.1997.tb08327.x","article-title":"Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis","volume":"110","author":"Short","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2022010901424758900_b9","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce nertrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022010901424758900_b10","first-page":"256","article-title":"Serum myeloperoxidase and serum cytokines in antimyeloperoxidase antibody-associated glomerulonephritis","volume":"40","author":"Arimura","year":"1993","journal-title":"Clin Nephrol"},{"key":"2022010901424758900_b11","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne","year":"1995","journal-title":"Q J Med"},{"key":"2022010901424758900_b12","first-page":"193","article-title":"Persistence of antineutropil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg\u2013Strauss syndrome: follow-up of 53 patients","volume":"13","author":"Cohen","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"2022010901424758900_b13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.1992.tb06944.x","article-title":"Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase","volume":"89","author":"Falk","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"2022010901424758900_b14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1023\/A:1023251001261","article-title":"A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO\u2013ANCA using recombinant hexamer histidine-tagged MPO deletion mutants","volume":"18","author":"Tomizawa","year":"1998","journal-title":"J Clin Immunol"},{"key":"2022010901424758900_b15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.1997.d01-895.x","article-title":"Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies","volume":"107","author":"Audrain","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"2022010901424758900_b16","first-page":"242","article-title":"Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO\u2013ANCA-associated glomerulonephritis","volume":"53","author":"Fujii","year":"2000","journal-title":"Clin Nephrol"},{"key":"2022010901424758900_b17","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/0006-2952(88)90574-6","article-title":"Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure","volume":"37","author":"Lee","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"2022010901424758900_b18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.7973636","article-title":"Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils","volume":"266","author":"Jiang","year":"1994","journal-title":"Science"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2004.02557.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/138\/1\/179\/42082379\/j.1365-2249.2004.02557.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/138\/1\/179\/42082379\/j.1365-2249.2004.02557.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T01:45:01Z","timestamp":1641692701000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/138\/1\/179\/6439753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,25]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,8,25]]},"published-print":{"date-parts":[[2004,8,31]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02557.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,10]]},"published":{"date-parts":[[2004,8,25]]}}}